Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford Biotrans is a biotechnology company spun out from the University of Oxford that specializes in enzymatic process technology for the production of high-value specialty chemicals. The company leverages a proprietary cytochrome P450 biocatalysis platform to develop sustainable and cost-effective routes to natural ingredients used in the flavor, fragrance, and pharmaceutical industries. Their flagship product is natural nootkatone, a high-value grapefruit flavor and scent produced through the enzymatic oxidation of valencene. By utilizing green, enzyme-based fermentation processes, Oxford Biotrans enables the production of 'natural' certified ingredients with a significantly lower environmental impact than traditional chemical synthesis. The company's technology is highly scalable and offers a cleaner alternative to conventional petrochemical-based manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxford Biotrans.